Infusion Pumps Market 2025 is Rising Internationally With: Baxter International, Smith Medical, Moog, ICU Medical,BD, Terumo Corporation, Medtronic, and Insulet Corporation
The market for infusion pumps is expected to grow significantly due to factors such as, increasing incidence of chronic diseases, increasing number of surgical procedures performed and growing geriatric population. In addition, rising medical tourism in developing countries is anticipated to have a positive impact on the growth of the infusion pumps market in the coming years.
Infusion pump is a device used to deliver liquids into a patient’s body in a regulated manner, the pump enables to deliver fluid in large and small amounts. The pump is used to deliver both nutrients and medication in the patient’s body. Infusion pumps are regularly used to administer critical fluids, including high-risk medications, pump failures can have significant implications for patient safety.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100001112/
The objective of the study is to describe, define, and forecast the infusion pumps market by type, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall infusion pumps market.
Volumetric pumps are driving the market for infusion pumps over the forecast period, in the type segment
The prominent players operating in infusion pumps market are BD, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche Ltd., Medtronic, Baxter International, Inc., Smith Medical, Moog, Inc., ICU Medical, Inc., and Insulet Corporation.
The market players are focused towards introducing new and innovative products in the market to sustain their position in the market. For instance, in December, 2018, Terumo Corporation announced that a biosimilar was launched in Europe. The biosimilar is used by company’s PLAJEX pre-fillable syringe. The hulio (biosimilar) is manufactured by the company. These product innovations and launches are expected to propel the growth of the infusion pumps market during the forecast period.
Buy the complete report @ https://www.theinsightpartners.com/buy/TIPHE100001112/
The plastic surgical procedures like liposuction, abdominoplasty, and mammoplasty, require short hospital stay, patients are discharged for ambulatory recovery on oral analgesic management. However, anesthetists have started using infusion pumps to achieve adequate outpatient analgesic control. These pumps continuously administer and maintain constant plasma concentrations. According to the American Society of Plastic Surgeons in 2017, there were around 17.5 million surgical and minimally invasive plastic procedures performed in the United States.
Also, according to the Centers for Disease Control and Prevention (CDC) every year about 735,000 people in suffer from a heart attack. Furthermore, the Johns Hopkins University has estimated that approximately 84 million people in the US suffer from some form of the cardiovascular disease. This has led to increase in cardiovascular surgeries.
Media Contact
Company Name: The Insight Partners
Contact Person: Sam J
Email: Send Email
Phone: +1-646-491-9876
Address:Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.theinsightpartners.com/reports/infusion-pumps-market/
